Skip to main content

Principal Securities, Inc.

SEC CIK
0000012600
Latest filing
Aug 4, 2026

IOVA holding history

Iovance Biotherapeutics, Inc. in every 13F filed by Principal Securities, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IOVA overviewAll 13F holders of IOVAFull Q2 2026 holdings

Shares (Q3 2024)
0
Sold out in Q3 2024
Value
$0
% of portfolio
0.0%
Quarters held
3
Since Q4 2023
Holdings of IOVA by Principal Securities, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20240$00.0%−127−100.0%Sold outHolders
Q2 2024127$1.02K<0.1%−12−8.6%ReducedHolders
Q1 2024139$2.06K<0.1%−359−72.1%ReducedHolders
Q4 2023498$4.05K<0.1%–No prior filingHolders